ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

S Otero-Romero, C Lebrun-Frénay… - Multiple Sclerosis …, 2023 - journals.sagepub.com
Background: With the new highly active drugs available for people with multiple sclerosis
(pwMS), vaccination becomes an essential part of the risk management strategy Objective …

[HTML][HTML] A new fractional mathematical model to study the impact of vaccination on COVID-19 outbreaks

S Bhatter, K Jangid, A Abidemi, KM Owolabi… - Decision Analytics …, 2023 - Elsevier
This study proposes a new fractional mathematical model to study the impact of vaccination
on COVID-19 outbreaks by categorizing infected people into non-vaccinated, first dose …

Bilateral optic neuritis and hypophysitis with diabetes insipidus 1 month after COVID-19 mRNA vaccine: case report and literature review

T Matsuo, K Okubo, H Mifune… - Journal of Investigative …, 2023 - journals.sagepub.com
Either optic neuritis (neuropathy) or hypopituitarism has been known to occur separately
after COVID-19 vaccination. In this report, we describe the rare combination of hypophysitis …

COVID-19 modified mRNA “vaccines”: Lessons learned from clinical trials, mass vaccination, and the bio-pharmaceutical complex, Part 2

MN Mead, S Seneff, J Rose, R Wolfinger… - International Journal of …, 2024 - ijvtpr.com
The COVID-19 modified mRNA (modmRNA) lipid nanoparticle-based “vaccines” are not
classical antigen-based vaccines but instead prodrugs informed by gene therapy …

European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple …

S Otero‐Romero, C Lebrun‐Frénay… - European Journal of …, 2023 - Wiley Online Library
Background and purpose With the new highly active drugs available for people with multiple
sclerosis (pwMS), vaccination becomes an essential part of the risk management strategy …

Neurological disorders following COVID-19 vaccination

Y Yang, L Huang - Vaccines, 2023 - mdpi.com
Nowadays, people all over the world have been receiving different types of coronavirus
disease 2019 (COVID-19) vaccines. While their effectiveness has been well recognized …

Frequency and predictors of relapses following SARS-CoV-2 vaccination in patients with multiple sclerosis: interim results from a longitudinal observational study

N Frahm, F Fneish, D Ellenberger, J Haas… - Journal of Clinical …, 2023 - mdpi.com
Despite protection from severe COVID-19 courses through vaccinations, some people with
multiple sclerosis (PwMS) are vaccination-hesitant due to fear of post-vaccination side …

Case report: first manifestation of multiple sclerosis temporally correlated with COVID-19 vaccination

A Czarnowska, K Kapica-Topczewska… - Frontiers in …, 2023 - frontiersin.org
There are several case reports describing a temporal correlation between the first clinical
manifestation of multiple sclerosis (MS) and the occurrence of relapses with vaccination …

Seasonal and monthly variation in multiple sclerosis relapses: a systematic review and meta-analysis

F Nabizadeh, P Valizadeh, M Yazdani Tabrizi… - Acta Neurologica …, 2022 - Springer
Abstract Background Multiple Sclerosis (MS) relapses are episodes of transient disease
exacerbation. There are contradictory findings regarding seasonal variation in MS relapses …

Post-COVID-19 depression and serum interleukin 6 levels: A systematic review and meta-analysis of COVID-19 convalescents with and without depression

H Seyedmirzaei, M Faramarzpour… - The World Journal of …, 2023 - Taylor & Francis
Objectives Depression is among the psychiatric sequelae of COVID-19, affecting more than
20% of the convalescents. Its underlying pathophysiology remains unclear. Interleukin 6 (IL …